Odiparcil QT Definitive Study
NCT00437242
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Fibrillation, Atrial
Atrial Fibrillation
Interventions
DRUG:
Odiparcil
Sponsor
GlaxoSmithKline